Imperial College London: Breast Neoplasms trials

The registry lists 12 Breast Neoplasms studies with Imperial College London as lead sponsor. 2 are open to participants now and 4 have results posted.

Phase 1 1Phase 2 5Phase 3 2No phase 5(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• BEAT-Breast: Trial of DE-iPTV in Patients With Primary Breast Cancer With Brain Metastases Who Are Not Suitable for Stereotactic Radiotherapy.RecruitingNCT06611306Not applicable
• HERPET- A Novel PET Imaging Study of HER2 in Breast CancerRecruitingNCT03827317Not applicable
• Behavioural Science Messages in Breast Cancer ScreeningCompletedNCT05395871Not applicableResults posted
• ALERT: A Phase II Study of Alternating Eribulin and Hormonal Therapy in Pre-treated ER+ve Breast Cancer.TerminatedNCT02681523Phase 2Results posted
• European Celecoxib Trial in Primary Breast CancerCompletedNCT02429427Phase 3Results posted
• AZD4547 & Anastrozole or Letrozole (NSAIs) in ER+ Breast Cancer Patients Who Have Progressed on NSAIs (RADICAL)CompletedNCT01791985Phase 1/2Results posted
• Effect of Capivasertib on ctDNA in ER Positive Breast CancerWithdrawnNCT06613516Phase 2
• D4 Choline Breast PET/CTCompletedNCT04276272
• A Study of the Safety and Effectiveness of Irosustat When Added to an AI in ER+ve Locally Advanced or Metastatic Breast Cancer.CompletedNCT01785992Phase 2
• A Study to Assess the Ability of a Novel Endocrine Treatment for Breast Cancer, Irosustat, to Slow Down Cancer GrowthTerminatedNCT01662726Phase 2
• Predictive Model of Therapy Outcomes in Breast Cancer PatientsCompletedNCT01563211
• Chemotherapy or Letrozole Before Surgery in Treating Postmenopausal Women With Breast Cancer That Can Be Removed By SurgeryCompletedNCT00963729Phase 3